Standard Operating Procedures: Pubertas Tarda/Delayed Puberty-Male

Journal of Sexual Medicine

Volumn 10, Issue 1, 2013, Pages 285-293

  Maggi, Mario ^a   Buvat, Jaques ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Centre d'Etude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique   (France)

Author keywords

Delayed Puberty; Hypogonadism; Male

Indexed keywords

GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT CHORIONIC GONADOTROPIN; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ANDROGEN THERAPY; ARTICLE; BONE AGE; DELAYED PUBERTY; DIAGNOSTIC PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; GONAD DEVELOPMENT; GONADOTROPIN DEFICIENCY; GYNECOMASTIA; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; LABORATORY TEST; MALE FERTILITY; MEDICAL HISTORY; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POLYCYTHEMIA; PREVALENCE; PRIORITY JOURNAL; SEXUAL MATURATION; TREATMENT PLANNING; UNITED STATES;

EID: 84872862900     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02678.x     Document Type: Article

References (21)

1. Grumbach MM, Styne DM. Puberty: Ontogeny, neuroendocrinology, phisiology and disorders. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology. 10th edition. Philadelphia: Saunders; 2003:1033.
2. Roche AF, Wellens R, Attie KM, Siervogel RM. The timing of sexual maturation in a group of US white youths. J Pediatr Endocrinol Metab 1995;8:11-8.
3. Harlan WR, Grillo GP, Cornoni-Huntley J, Leaverton PE. Secondary sex characteristics of boys 12 to 17 years of age: The U.S. Health Examination Survey. J Pediatr 1979;95:293-7.
4. Sedlmeyer IL, Palmert MR. Delayed puberty: Analysis of a large case series from an academic center. J Clin Endocrinol Metab 2002;87:1613-20.
5. Pozo J, Argente J. Delayed puberty in chronic illness. Best Pract Res Clin Endocrinol Metab 2002;16:73-90.
6. Bauman A. Markedly delayed puberty or Kallmann's syndrome variant. J Androl 1986;7:224-7.
7. Quinton R, Cheow HK, Tymms DJ, Bouloux PM, Wu FC, Jacobs HS. Kallmann's syndrome: Is it always for life? Clin Endocrinol 1999;50:481-5.
8. Pitteloud N, Acierno JS Jr, Meysing AU, Dwyer AA, Hayes FJ, Crowley WF Jr. Reversible Kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J Clin Endocrinol Metab 2005;90:1317-22.
9. Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, Cole LW, Pearce SH, Lee H, Boepple P, Crowley WF Jr, Pitteloud N. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 2007;357:863-73.
10. Ribeiro RS, Vieira TC, Abucham J. Reversible Kallmann syndrome: Report of the first case with a KAL1 mutation and literature review. Eur J Endocrinol 2007;156:285-90.
11. Morelli A, Fibbi B, Marini M, Silvestrini E, De Vita G, Chavalmane AK, Vignozzi L, Filippi S, Forti G, Vannelli GB, Maggi M. Dihydrotestosterone and leptin regulate gonadotropin-releasing hormone (GnRH) expression and secretion in human GnRH-secreting neuroblasts. J Sex Med 2009;6:397-407.
12. Ghai K, Cara JF, Rosenfield RL. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys-A clinical research center study. J Clin Endocrinol Metab 1995;80:2980-6.
13. Wu FC, Brown DC, Butler GE, Stirling HF, Kelnar CJ. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys. J Clin Endocrinol Metab 1993;76:26-31.
14. Arrigo T, Cisternino M, Luca De F, Saggese G, Messina MF, Pasquino AM, De Sanctis V. Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty. J Pediatr Endocrinol Metab 1996;9:511-7.
15. Butler GE, Sellar RE, Walker RF, Hendry M, Kelnar CJ, Wu FC. Oral testosterone undecanoate in the management of delayed puberty in boys: Pharmacokinetics and effects on sexual maturation and growth. J Clin Endocrinol Metab 1992;75:37-44.
16. Rosenfeld RG, Northcraft GB, Hintz RL. A prospective, randomized trial of testosterone treatment of constitutional short stature in adolescent males. Pediatrics 1982;69:681-7.
17. Richman RA, Kirsch LR. Testosterone treatment in adolescent boys with constitutional delay in growth and development. N Engl J Med 1988;319:1563-7.
18. Delemarre EM, Felius B, Delemarre-van de Waal HA. Inducing puberty. Eur J Endocrinol 2008;159(suppl 1):S9-15.
19. Thau RB, Goldstein M, Yamamoto Y, Burrow GN, Phillips D, Bardin CW. Failure of gonadotropin therapy secondary to chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab 1988;66:862-7.
20. Han TS, Bouloux PM. What is the optimal therapy for young males with hypogonadotropic hypogonadism? Clin Endocrinol 2010;72:731-7.
21. Giagulli VA, Triggiani V, Carbone MD, Corona G, Tafaro E, Licchelli B, Guastamacchia E. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism. J Sex Med 2011;8:3471-8.